Robert Grundstein
@Sabby Management, Llc
Latest period2024 - Q3ReportedManaged Assets$186.418MTotal holdings42
Assets growth rate-99.87%Assets growth rate (2-Q avg)-57.03%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sabby Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.
Assets under management
The assets under management (AUM) of Sabby Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 186.418M in assets, with a quarterly growth rate of -99.87% and a 2-quarter average growth rate of -57.03%. The portfolio is managed by Robert Grundstein, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
GEVOGevo Inc
| 0% | $139.3M 250,000 shares@ $557.2 avg price | Exited |
NEXINeximmune Inc
| 0% | $137.73M 49,904 shares@ $2759.9 avg price | Exited |
SMFLSmart For Life Inc
| 0% | $102.132M 34,504 shares@ $2960.01 avg price | Exited |
CHNRChina Natural Resources Inc
| 0% | $82.161M 104,931 shares@ $783.01 avg price | Exited |
INMInmed Pharmaceuticals Inc
| 0% | $81.571M 307,236 shares@ $265.5 avg price | Exited |
3743⤦Gevo Inc
| 0% | $70.096M↑ Call 1,258 shares@ $55720.2 avg price | Exited |
SCNIBiondvax Pharmaceuticals Ltd
| 0% | $49.562M 17,828 shares@ $2780.01 avg price | Exited |
APDNApplied Dna Sciences Inc
| 0% | $28.777M 70,463 shares@ $408.4 avg price | Exited |
8677⤦Sunshine Biopharma Inc
| 0% | $8.35M 20,000 shares@ $417.5 avg price | Exited |
CINGWCingulate Inc
| 0% | $4.952M 458,522 shares@ $10.8 avg price | Exited |